Cabaletta Bio

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Cullinan Oncology

This company develops therapies for patients living with autoimmune diseases and cancer.

Boulevard Bio

This clinical-stage biotechnology company develops multi-specific antibody therapies for patients suffering from B cell-driven autoimmune diseases.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Cartesian Therapeutics

This clinical-stage biotechnology company develops mRNA cell therapies for patients with autoimmune diseases, including myasthenia gravis and myositis.